Long Head of Biceps as an Anterior Dynamic Sling for Recurrent Anterior Shoulder Dislocation
Launched by CAIRO UNIVERSITY · Mar 6, 2025
Trial Information
Current as of September 24, 2025
Completed
Keywords
ClinConnect Summary
Twenty-five patients underwent arthroscopic DAS using LHB between March 2022 and October 2022 for treatment of anterior glenohumeral instability (AGI) with limited to subcritical glenoid bone loss (GBL) were included in a prospective study with a minimum follow-up period of 2 years. The shoulder functional outcomes were assessed using the Rowe and the Quick Disabilities of Arm, Shoulder and Hand (Quick DASH) scores both preoperative and at 2 years follow-up. Magnetic resonance imaging (MRI) at 6 months after surgery to evaluate LHB tendon healing to the anterior glenoid.
Gender
ALL
Eligibility criteria
- • The inclusion criteria were
- • Patients complaining of AGI, with one or more events of anterior shoulder dislocation.
- • Associated limited (\<13.5%) to subcritical (\<25%) GBL.
- • Positive anterior shoulder apprehension.
- • The exclusion criteria were
- • Associated critical GBL (≥25%).
- • Concomitant LHB lesion or rupture.
- • Multidirectional or voluntary shoulder instability.
- • Prior arthroscopic shoulder stabilization procedure.
- • Concomitant rotator cuff tears.
- • Acute proximal humerus fractures of the involved shoulder.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Giza, Cairo, Egypt
Patients applied
Trial Officials
mohamed H khalil, M.D
Principal Investigator
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported